December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

8.910 -0.100 (-1.11%)
Streaming Delayed Price Updated: 1:08 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio's Cancer Candidate Shows Anti-Tumor Activity In Preclinical Study ↗
Adicet Bio Inc (NASDAQ: ACET)  
Via Benzinga
News headline image
Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
7 Biotech Stocks With Huge Return Potential for Long-Term Investors ↗
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
News headline image
Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
News headline image
7 Biotech Stocks That Could Be the Next Big Thing ↗
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
Via InvestorPlace
News headline image
Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference
From Adicet Bio, Inc.
Via Business Wire
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday's session saw 16 companies set new 52-week lows. 
Via Benzinga
News headline image
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
News headline image
Peering Into Adicet Bio's Recent Short Interest ↗
Adicet Bio's (NASDAQ:ACET) short percent of float has risen 29.62% since its last report. The company recently reported that it has 4.02 million shares sold short, which is 12.56% of all regular shares... 
Via Benzinga
News headline image
Dow Surges Over 250 Points; Weber Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday 
Via Benzinga
News headline image
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
News headline image
Stocks Hold Gains Ahead Of Tuesday's Economic Flurry ↗
The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Rises Sharply; Adicet Bio Shares Plunge ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday 
Via Benzinga
News headline image
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Adicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study ↗
 
Via Benzinga
News headline image
US Stocks Higher; Dow Rises Over 100 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Monday 
Via Benzinga
News headline image
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.